Drugmaker Preps Market for Diet Pill

May 22, 2007 By CANDICE CHOI, AP Business Writer
Drugmaker Preps Market for Diet Pill (AP)
Steven Burton, vice president weight control division of GlaxoSmithKline Consumer Healthcare, displays a starter pack of alli, the first over-the-counter diet pill approved by the Food and Drug Administration, in New York, Tuesday, May 22, 2007. In clinical trials, the FDA says that people using alli lost an additional 2 to 3 pounds for every 5 pounds lost through diet and exercise. (AP Photo/Richard Drew)

(AP) -- You won't lose weight in your sleep or shed pounds while eating anything you want - that's the sobering message from the maker of a weight loss pill poised to hit shelves next month.



Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Explore further: Analgesics prescribed more heavily to women than to men, study finds

add to favorites email to friend print save as pdf

Related Stories

Moore tornado a rarity, experts say

just added

Tornados, among the most violent of atmospheric storms, rarely reach the size and brutality of the twister that swept through an Oklahoma City suburb on Monday, experts say.

Dubai seizes 259 smuggled African ivory tusks

28 minutes ago

A shipment of 259 elephant tusks smuggled out of Africa has been seized in the United Arab Emirates, the International Wildlife Fund for Animal Welfare said Tuesday.

Recommended for you

FDA has safety concerns on Merck insomnia drug

May 20, 2013

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

US adviser on board of firm that sold anthrax drug

May 20, 2013

(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...

First influenza vaccine brought to clinical testing

May 17, 2013

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

User comments : 0

More news stories

Game system castAR debuts at Maker Faire

(Phys.org) —Two tech talents, formerly employees at video game publisher Valve, have been working on their own vision in the form of game-ready glasses. Their company, Technical Illusions, will seek to ...

Glaucoma drug can cause droopy eyelids

Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...

How gold nanoparticles can help fight ovarian cancer

Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why, and determined how to make the nanoparticles effective ...